vaginitis
Information
- Disease name
- vaginitis
- Disease ID
- DOID:2170
- Description
- "A vaginal disease that is characterized by inflammation of the vagina." [url:https\://www.ncbi.nlm.nih.gov/pubmed/21524046]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00137371 | Completed | Phase 3 | Study Evaluating Conjugated Estrogen Cream for Atrophic Vaginitis | August 2005 | September 2007 |
| NCT00313131 | Completed | Phase 3 | Study of the Management of Vaginal Discharge in West African Using Single Dose Treatments | January 2004 | May 2005 |
| NCT00503542 | Completed | Early Phase 1 | Management of Vaginal Complaints: A Pilot Study Within a Practice-Based Research Network | February 2007 | February 2008 |
| NCT00616330 | Completed | Phase 3 | Vaginal Infection Study | January 2008 | December 2009 |
| NCT00634608 | Completed | N/A | Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow | February 2008 | September 2009 |
| NCT00803127 | Completed | VS-Sense Result Reading Clarity | January 2009 | May 2009 | |
| NCT01050465 | Completed | N/A | MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use | May 2009 | December 2010 |
| NCT01867164 | Completed | Phase 3 | A Study to Compare Efficacy and Safety of an Ovule Containing Terconazole, Clindamycin and Fluocinolone Versus an Ovule Containing Metronidazole, Nystatin and Fluocinolone in the Treatment of Secondary Vulvar/ or Vaginal Symptoms of Infectious Vaginitis/ and Infectious Vaginosis | December 2007 | December 2008 |
| NCT02365389 | Completed | Phase 2/Phase 3 | Once Daily In-situ Forming Versus Twice-daily Conventional Metronidazole Vaginal Gels for Treatment of Bacterial Vaginosis | May 2014 | December 2014 |
| NCT02444481 | Completed | Phase 4 | Open Study of the Efficacy of the Local Treatment With Polygynax of Bacterial and/or Mycotic Vaginitis | April 2009 | November 2009 |
| NCT02515656 | Completed | Phase 3 | Assessment of the Efficacy of POLYGYNAX® in the Empirical Treatment of Infectious Vaginitis | September 2015 | August 2016 |
| NCT02641717 | Completed | N/A | Validity of Patient-Collected Wet Mounts | November 2015 | August 2016 |
| NCT03151928 | Completed | Diagnostic Accuracy By Providers Study | July 6, 2017 | August 15, 2018 | |
| NCT03585049 | Completed | Microscopic Images for the Development of a Rapid Vaginitis Diagnostic Device | October 1, 2018 | December 1, 2022 | |
| NCT04079218 | Completed | Phase 4 | Accelerated Genital Tract Aging in HIV: Estradiol Clinical Trial | September 1, 2020 | August 9, 2023 |
| NCT04676503 | Completed | N/A | Vaginal and Rectal Colonization of Lactobacillus Crispatus NTCVAG04 Following Oral Administration in Patients With History of Vaginitis/Vaginosis | November 22, 2019 | July 21, 2020 |
| NCT05396261 | Completed | N/A | a Flexible Wound Dressing for the Management of Genital Skin Conditions | January 31, 2018 | February 1, 2022 |
| NCT05652959 | Completed | Real-world Performance and Safety of Cerviron® in the Treatment of Vaginitis | May 20, 2021 | May 30, 2022 | |
| NCT05670535 | Completed | Sjögren and Gynecologic Considerations | March 1, 2021 | November 10, 2022 | |
| NCT05882851 | Completed | Effect of Nutrition in the Treatment of Vaginitis | January 1, 2022 | April 30, 2022 | |
| NCT01436513 | Completed | Phase 1 | A Study To Compare The Amount Of Premarin Components That Is Absorbed Into The Blood Of Japanese Healthy Postmenopausal Women Following Oral Administration Of Two Different Tablets Of Premarin Under Fast and Fed Conditions. | October 2011 | March 2012 |
| NCT06438575 | Not yet recruiting | N/A | Point of Care Diagnosis of Vaginal Infections | June 2024 | December 2025 |
| NCT06070454 | Not yet recruiting | N/A | Prospective Evaluation of Infectious Vulvovaginitis on Wound Complication Rates After Vulvar Excision for Premalignant Lesions | November 14, 2023 | November 14, 2025 |
| NCT04574089 | Recruiting | Phase 3 | Treatment for Aerobic Vaginitis by Using Bofukang Vaginal Suppository | May 1, 2020 | December 30, 2024 |
| NCT06165354 | Recruiting | N/A | Effects of LiveSpo X-SECRET in SupportiveTreatment of Vaginitis | December 22, 2023 | December 2024 |
| NCT05587283 | Recruiting | Phase 1 | Safety, Tolerability, and Acceptability Study of Intravaginal Administration of LABTHERA-001 Capsules in Healthy Women | November 2, 2022 | May 2023 |
| NCT05557318 | Recruiting | N/A | Using Micro Electro Mechanical Systems to Detect the Air of Vaginal Discharge | October 8, 2022 | October 2025 |
| NCT01122342 | Suspended | Phase 1/Phase 2 | Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer. | December 2006 | January 2011 |
| NCT04984460 | Unknown status | Morphological Detection of Liquid-based Thin-layer Film-making Fungi for Fungal Vaginitis in Multiple Hospitals | July 9, 2021 | April 1, 2023 | |
| NCT04885556 | Unknown status | N/A | Evaluation of a Novel Female Hygiene Device for Postcoital Discomfort | April 5, 2021 | September 15, 2021 |
| NCT02763696 | Unknown status | Establishment of a Sensitive System for Analysis of Child-bearing Women Vaginal Microbiota | May 10, 2016 | December 2018 | |
| NCT04816903 | Unknown status | N/A | Gyni™ Study With Leumit Health Services | March 7, 2021 | March 7, 2022 |
| NCT01420510 | Unknown status | Phase 2/Phase 3 | Saginil in vs. Placebo for Gynecologic Oncology Patients Affected by Vaginitis | September 2011 | December 2014 |
| NCT02316249 | Withdrawn | Phase 2 | Vaginal Creams to Reduce Vaginal Erosion in Pessary Users | April 2015 | August 2015 |
- Disase is a (Disease Ontology)
- DOID:121
- Cross Reference ID (Disease Ontology)
- ICD9CM:616.1
- Cross Reference ID (Disease Ontology)
- MESH:D014627
- Cross Reference ID (Disease Ontology)
- NCI:C26911
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:198212006
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:393596009
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0042267
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0042268
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0030683
- MeSH unique ID (MeSH (Medical Subject Headings))
- D014627